serologic testing

OTHER2 trials

Sponsors

Goethe University, Mayo Clinic

Conditions

COVID-19CancerHIV-1 InfectionImmunosuppressionSARS-CoV 2

Phase 4

Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients

Goethe UniversityCancer, HIV-1 Infection, Immunosuppression

Start: 2009-11-30End: 2010-03-31Target: 500Updated: 2009-11-20

Unknown Phase

Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers

CompletedNCT04383587

Mayo ClinicCOVID-19, SARS-CoV 2

Start: 2020-05-06End: 2020-07-31Updated: 2022-04-13

Related Papers

Immune response after a single dose of the 2010/11 trivalent, seasonal influenza vaccine in HIV-1-infected patients and healthy controls.

2013-07-019 citations

Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation.

2011-02-1328 citations

Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.

2011-01-0148 citations

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients.

2010-06-0156 citations